UNASSIGNED: Here, 221 patients with BOTs confirmed by postoperative pathology were enrolled. Their clinical data, including the ultrasonography features, tumor markers, and clinicopathological data, were retrospectively analyzed.
UNASSIGNED: The statistical data of the 221 cases with BOTs were as follows: 94 (42.5%) with left-sided lesions, 102 (46.2%) with right-sided lesions, and 25 (11.3%) with bilateral lesions. Moreover, 93 cases (42.1%) had a borderline serous tumor, 110 (49.8%) had a borderline mucinous tumor, 12 (5.4%) had a borderline serous mucinous tumor, 2 (0.9%) had a borderline endometrioid tumor, 1 (0.5%) had a borderline Brenner tumor, and 2 (0.9%) had a clear cell BOT. There were 104 cases (47.1%) with a tumor diameter of ≤10 cm and 117 cases (52.9%) with a tumor diameter of >10 cm as suggested by ultrasonography. There were 89 cases (40.3%) with septation, 44 (19.9%) with papilla, and 97 (43.9%) with blood flow as demonstrated by ultrasonography. Carbohydrate antigen 125 (CA 125) was elevated in 132 cases (59.7%), and CA 19-9 was elevated in 52 cases (23.5%).
UNASSIGNED: In general, BOTs are difficult to diagnose preoperatively and have a certain recurrence rate. Ultrasonography combined with CA 125 and CA 19-9 is significant for the preoperative diagnosis and selection of surgical modality for BOTs and could be used as a guideline to achieve good preoperative preparation and avoid secondary surgery.
未经评估:这里,纳入221例经术后病理证实的BOTs患者。他们的临床数据,包括超声检查的特征,肿瘤标志物,和临床病理数据,进行回顾性分析。
UNASSIGNED:221例BOT患者的统计数据如下:94例(42.5%)左侧病变,102例(46.2%)右侧病变,双侧病变25例(11.3%)。此外,93例(42.1%)有交界性浆液性肿瘤,110例(49.8%)有交界性粘液性肿瘤,12例(5.4%)患有交界性浆液性粘液性肿瘤,2(0.9%)患有交界性子宫内膜样肿瘤,1人(0.5%)患有边缘Brenner肿瘤,2例(0.9%)有透明细胞BOT。超声提示肿瘤直径≤10cm104例(47.1%),肿瘤直径>10cm117例(52.9%)。有89例(40.3%)发生中隔,44(19.9%)有乳头,超声检查显示血流97(43.9%)。糖抗原125(CA125)升高132例(59.7%),CA19-9升高52例(23.5%)。
未经评估:一般来说,BOTs术前诊断困难,有一定的复发率。超声联合CA125和CA19-9对BOT的术前诊断和手术方式的选择具有重要意义,可作为实现良好的术前准备和避免二次手术的指南。